Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: September 15, 2010

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Zirgan New Drug Initial Review Remove Prior Approval Requirement Prior Approval Requirement Removed
Oravig New Drug Initial Review Require Prior Approval Prior Approval Required
Cetraxal New Drug Initial Review Remove Prior Approval Requirement Prior Approval Requirement Removed
Lysteda New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Oleptro New Drug Initial Review Require Prior Approval Prior Approval Required
Pancreaze New Drug Initial Review Require Prior Approval Prior Approval Required
Xifaxan 550 New Drug Appeal Require Prior Approval Prior Approval Required
Bepreve New Drug Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed
Colcrys New Drug Appeal Require Prior Approval Prior Approval Required
Fanapt New Drug Appeal Removed from Agenda Prior to Mtg Prior Approval Required
Pristiq New Drug Appeal Require Prior Approval Prior Approval Required
Saphris PDL Appeal Remove Prior Approval Requirement Prior Approval Required
Vesicare PDL Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed